Pfizer has ER next week and 5/20 calls sweeping today Technically it looks like we can get a run up to ER , as PFE is at trendline support and possible "fill out" of the triangle pattern Any run up will capture some gains, will trim position and leave a few runners for ER. Sweeps were 55.5 and 57 strike which are pretty far out the money, worth noting. Could...
i circil around the coins between exchanges and i found this beautiful chart of #fil #coin that we have here,its on daily support zone and despite how critical #bitcoin is right now it can clearly take the road to the highest level it can be! #stay #safe and as i always use to say "whatever can happen on a chart,will happen and theres nothing you can do to stop it"
As per previously modelled, the projection based on public data on cases project that in early May, Singapore should start the next wave... for now, it looks like a mild spike given the momentum trajectory. 26 April is when more measures are lifted, and rules are further eased... to pre-pandemic level " almost all the way to how things were " So far, model is...
ALERS EUROBIO SCIENTIFIC is a company on the French stock market in the vitro medical diagnostics and also producing CAVID19 tests. It made a nice CUP & Handle BO with volume EURONEXT:ALERS EURONEXT:ALERS ://www.tradingview.com/x/Uw1WlyDV/]https://www.tradingview.com/x/Uw1WlyDV/
The Australian dollar has extended its losses today, as AUD/USD trades just above the 0.74 line in the European session. It has been a rough stretch for the currency, which has managed just one winning session since April 5th. The Australian dollar has been hurt by the Fed-powered US dollar as well as concerns about China's growth, as the country grapples with an...
ARDS Aridis Pharmaceuticals has 2 Phase 3 Clinical Trials for 2022, one Phase 2a study, a fully human monoclonal antibody (mAb) cocktail against COVID and a funding from the Gates Foundation to support development of inhaled formulation technology to deliver cost-effective monoclonal antibodies against influenza and COVID-19. And the Market Cap is only...
NRx Pharmaceuticals, Inc. (NRXP) has two Phase III assets for which it has Fast Track and Breakthrough Therapy designation, respectively: intravenous ZYESAMI® for Critical COVID-19 and NRX-101 for bipolar depression with suicidality. 52 Week Range 2.38 - 48.80. in 2020 the stock was $77. My price target is 16.50 If this is not the time to buy this stock, then when?!
After a strong week, the Australian dollar has reversed directions and dropped below the 0.75 line on Monday. Investors will be keeping an eye on Australian retail sales, which will be released on Tuesday. The markets are expecting a gain of 1.0%, down from 1.8% in January. The month of March has been kind to the Australian dollar, with sharp gains of 3.47%....
Bitcoin leads the way as investors seek adaptable hedging alternatives in the search for the new digital gold. Gold has served as a store of value for thousands of years. Due to this, investors have widely used it as a hedging tool against the effects of recessions and inflation often caused by geopolitical tensions. In light of recent events such as the COVID-19...
Just an observation here... I have been posting much about using the MACD Histograms to project the spikes and waves of COVID-19 infections, given the data collated on this platform. So far, it has been pretty uncanny in accuracy. Just coming across the Total COVID-19 Confirmed Infections chart, there appears to be an odd divergence on the MACD histograms.. and...
... to spike in April! Already media is openly speaking of that expectation. No surprises, will happen. Data (MACD histogram) projections align. Apparently, NY and FL are already spiking. This is likely the Omicron wave, and it can get out of hand pretty quickly as we have seen in many other countries. Hope that enough preparations have been made!
A week after calling the levelling off in reported infections, it did just that and few days later, the SG Health Minister's statement says that the omicron peak is over . From the past few days, the ebb is slowing and the drop in infections appears to be picking up again. Do remember that virus infections are not exactly linear in amounts and in time as well....
WXY correctiong is on a the Y wave of the correction. The geopolitic situation and the rise in covid cases and lockdown impossed by China is expected to put pressure on AUD, NZD and CAD due to hi beta status
Inflation in the US markets hit 7.9% last month - while the Federal Reserve was claiming that inflation was "transitory" all of 2021, realizing the US dollar may be in risk of systemic collapse they finally started to consider the possibility of raising interest rates (it's been near 0% for almost a decade now) -- arguably their only weapon to combat inflation at...
Wave 4 (Omicron) appears to be tapering off, we would be able to know better in the latter part of March. For now, it would appear that the projection sees a rather steep tapering of COVID cases into end of March. Good news! Not positive! lol...
This might be just a simple charting of the fall from grace for Pfizer (PFE), Moderna (MRNA) and BioNTech (BNTX). Compare the dates of dips with press coverage of fading covid19 efficiency and emerging adverse effects and the story becomes more complicated.
At the start of the year, it was clear that the Omicron wave (Wave 4) started, as heads up by the previous post. Wave 4 is ON now. In the coming weeks, it starts slow, but will accelerate faster and faster, into March and April 2022 In the last two months, we can see that the infection rate escalated after the turn into February. Depicted by the white and...
UK retail sales rebounded in January, with a gain of 1.9% m/m, its highest monthly gain since April 2021. The increase followed a decline of 4.0% in December and beat the consensus of 1.0%. The Omicron variant of corona continues to have a significant impact on consumer spending. The December drop was a result of consumers doing their Christmas shopping in October...